<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="160107">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01014377</url>
  </required_header>
  <id_info>
    <org_study_id>VAS-01</org_study_id>
    <nct_id>NCT01014377</nct_id>
  </id_info>
  <brief_title>Effect of VascuActive Device on Foot Perfusion, Hemodynamics and Exercise Capacity in Patients With PVD &amp; Limb Ischemia</brief_title>
  <official_title>Assessment of the Safety of the VascuActiveâ„¢ Device and Its Preliminary Efficacy on Foot Perfusion, Hemodynamics and Exercise Capacity in Patients With Peripheral Vascular Disease and Limb Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VascuActive LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VascuActive LTD</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and the immediate effect of the
      VascuActive device on patients with peripheral vascular disease and limb ischemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain-free and Maximal walking distance</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin temperature</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin blood flow</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous partial pressure of O2 and CO2</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VascuActive</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Leg Ischemia, Fontaine grade IIa and IIb, i.e.: pain free walking distance in the
             range of 50 - 100 meters.

          -  Absent pulses in the two foot arteries (Anterior Tibial a., Posterior Tibial a.)

          -  ABI &lt; 0.7 by Doppler, in at least one of the two foot arteries

        Exclusion Criteria:

          -  Absent femoral pulses

          -  Venous insufficiency by Duplex

          -  Pregnancy

          -  Infectious disease

          -  Malignant disease

          -  Severe cardiac disease, e.g., CHF grade 3 or higher

          -  Acute MI within last 3 months

          -  CABG within last 3 months

          -  Other severe systemic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asaf Harofe Medical Center</name>
      <address>
        <city>Zrifin</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <lastchanged_date>May 20, 2010</lastchanged_date>
  <firstreceived_date>November 11, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Yuval Avni</name_title>
    <organization>VascuActive LTD</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
